Precision NanoSystem
Vancouver
About Precision NanoSystem
Precision Nanosystems develops tools and processes for the development and manufacture of nanoparticles for use as medicines and in medical research. It offers NanoAssemblr benchtop instrument for prototyping of nanoparticles, as well as for the development of nanoparticle-based drugs delivering RNA, small-molecule, and protein therapeutics. The company also provides Neuro9Kit for the study of gene function in neurons and glial cells, as well as potent delivery to primary cells; Test9Kit for the study of gene function in various cell types; and Hepato9Kit for the study of gene function in the liver. In addition, it provides instruments, reagents, and services to the life sciences researchers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $37.6M
- Funding stage: M&A
- Last round: Grant (Oct 2020)
- Website: precisionnanosystems.com
- Phone: (888) 618-0031
Industries & Categories
Biotechnology, Genetics, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/precision-nanosystem-25492 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.